Medical Devices to Revolutionize with Integration of Cloud, IoT and AI
November 5, 2020 | PR NewswireEstimated reading time: 1 minute
Frost & Sullivan's recent analysis, Pipeline Analysis of Phase III Medical Therapeutic Devices: The Potential Game Changers and Growth Enablers, finds that the technology developmental trend for pipeline therapeutic medical devices in the late stage (Phase-III) of clinical development or clinical trial is shifting towards manufacturing portable, lightweight, and easy-to-use devices for patients, allowing their use in home settings. The integration of therapeutic medical devices with digital technologies aims to increase patient engagement and improve the treatment outcome for their disease condition, especially during and post the COVID-19 pandemic.
"Therapeutic medical devices delivering energy or electric fields non-invasively to the specific affected sites and eliminating systemic side effects can explore business opportunities in chronic diseases in oncology and neurology," said Ashish Kaul, Technical Insights Senior Research Analyst at Frost & Sullivan. "Going forward, advance manufacturing technology such as 3D printing can enable medtech companies to meet the market need in case of urgencies such as COVID-19 pandemic or high market demand for fast manufacturing."
Kaul added: "Medical device companies are exploring different biodegradable and recyclable plastic material to include it in its manufacturing process. Additionally, this use of biodegradable and recyclable materials in home-based therapeutic medical devices will increase significantly in the next five to six years."
The increasing permeation of therapeutic medical devices with digital technologies such as mobile applications presents immense growth prospects for market participants, including:
- Innovative non-invasive, lightweight, miniaturized, and portable medical devices can be developed using printed electronics components such as sensors and circuits.
- Needle-less and self-use medical devices can be developed to eliminate painful experiences during self-injection activities.
Therapeutic medical devices can be integrated with a cloud system, internet of things (IoT), and artificial intelligence (AI) so that the information collected by the devices can be analyzed and used for advanced research to understand complex diseases and develop effective treatments.
Suggested Items
iNEMI Names Grace O'Malley CTO
05/02/2024 | iNEMIThe Board of Directors of the International Electronics Manufacturing Initiative (iNEMI) has named Grace O'Malley Chief Technical Officer (CTO).
Intel Takes Next Step Toward Building Scalable Silicon-Based Quantum Processors
05/02/2024 | BUSINESS WIRENature published an Intel research paper, “Probing single electrons across 300-mm spin qubit wafers,” demonstrating state-of-the-art uniformity, fidelity and measurement statistics of spin qubits.
ZESTRON Academy Launches 2024 Advanced Packaging & Power Electronics Webinar Series
05/01/2024 | ZESTRONZESTRON, the leading global provider of high-precision cleaning products, services, and training solutions in the electronics manufacturing and semiconductor industries, proudly announces the launch of its highly anticipated webinar series on Advanced Packaging & Power Electronics, a webinar series on the latest innovations, cleaning, and corrosion challenges.
NextFlex Convenes the Hybrid Electronics Community at Binghamton University
05/01/2024 | NextFlexBinghamton University hosted the NextFlex hybrid electronics community on April 18 for a day of expert presentations, breakout sessions on technology and manufacturing topics, and networking.
HQ NextPCB of HQ Electronics Debut on the International Stage for Electronics Manufacture at IPC APEX 2024
05/01/2024 | PRNewswireHQ NextPCB of HQ Electronics, a leading Chinese-based multilayer PCB manufacturer and assembly house showcased its industrial prowess on the international stage for the first time at the IPC APEX Expo 2024.